Newsroom

NEW YORK--(BUSINESS WIRE)--Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Franklin BSP Realty Trust, Inc. (“Franklin” or the “Company”) (NYSE: FBRT) and reminds investors of the April 27, 2026 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgi...

SCHAUMBURG, Ill.--(BUSINESS WIRE)--Ascent Industries Co. (Nasdaq: ACNT) (“Ascent” or the “Company”), a specialty chemicals platform focused on the development, production, and distribution of tailored, performance-driven chemical solutions, will hold a conference call on Wednesday, May 6, 2026, at 5:00 p.m. Eastern time to discuss its financial results for the first quarter ended March 31, 2026. The results will be reported in a press release prior to the conference call. Ascent management will...

NASHVILLE, Tenn.--(BUSINESS WIRE)--RJ Young, a leading provider of office technology solutions and managed services, today announced an expansion of its growing partnership with Xerox. Under this expanded agreement, RJ Young will now provide technical services for all Xerox clients, with sales support for SMB clients, across Tennessee, Mississippi, and West Virginia. This strategic expansion enhances RJ Young’s ability to deliver best-in-class service, innovative technology solutions, and local...

CAMBRIDGE, Inglaterra--(BUSINESS WIRE)--  Mundipharma anuncia resultados positivos preliminares del estudio de Fase III ReSPECT que evalúa ▼ REZZAYO® (rezafungina) para la profilaxis de enfermedades fúngicas invasivas en pacientes sometidos a trasplante alogénico de células madre hematopoyéticas   Mundipharma anunció hoy resultados preliminares positivos de Fase III del estudio clínico global ReSPECT, que evaluó REZZAYO® (acetato de rezafungina) para la profilaxis de enfermedades fúngicas invas...

NEW YORK--(BUSINESS WIRE)--Humanforce, a leading global provider of intelligent, AI-driven human capital management (HCM) solutions for frontline workforces, today announced a strategic partnership with Kroenke Sports & Entertainment (KSE) to optimize workforce management across KSE Colorado venues. The partnership encompasses Ball Arena, home of the Denver Nuggets and Colorado Avalanche, DICK’S Sporting Goods Park, where the Colorado Rapids compete, and Paramount Theatre. In particular, Ba...

TORONTO--(BUSINESS WIRE)--The Ford government must act now to protect the “Little Guy” and make Workplace Safety and Insurance Board (WSIB) coverage universal for all Ontario workers. Ahead of Canada’s National Day of Mourning (April 28), CUPE 1750, the Ontario Compensation Employees Union (OCEU) is reminding the public and the media that every worker has the right to come home from work safe and whole – and that includes a workers’ compensation system that is both fair and fully inclusive. Uni...

ATLANTA--(BUSINESS WIRE)--Domain Capital Group today announced the launch of its Sports Credit Strategy and the closing of a new separately managed account focused on receivables tied to European football player transfers and media rights. The launch brings together the expertise and capabilities of Domain’s separate credit and entertainment investment teams and follows the recent final close of Domain Entertainment Fund II, with more than $768 million in commitments. Through the account, Domai...

CAMBRIDGE, Angleterre--(BUSINESS WIRE)--  Mundipharma annonce les premiers résultats positifs de l’essai de phase III ReSPECT évaluant ▼ REZZAYO® (rézafungine) dans la prophylaxie des infections fongiques invasives chez les patients ayant subi une greffe allogénique de cellules souches hématopoïétiques   Mundipharma a annoncé aujourd’hui les premiers résultats positifs de phase III de l’essai clinique mondial ReSPECT évaluant REZZAYO® (acétate de rézafungine) dans la prophylaxie des maladies fo...

MUMBAI, India y JERSEY CITY, Nueva Jersey--(BUSINESS WIRE)--Sun Pharmaceutical Industries Limited (Reuters: SUN.BO, Bloomberg: SUNP IN, NSE: SUNPHARMA, BSE: 524715) (junto con sus filiales y/o empresas vinculadas, “Sun Pharma”) y Organon & Co. (NYSE: OGN) (“Organon”) anunciaron hoy la firma de un acuerdo definitivo en virtud del cual Sun Pharma adquirirá la totalidad de las acciones en circulación de Organon por US$ 14,00 por acción, en una operación íntegramente en efectivo que valúa a Org...

英國劍橋--(BUSINESS WIRE)--(美國商業資訊)-- Mundipharma今日宣布，其全球性ReSPECT臨床試驗取得了積極的III期頂線結果。該試驗旨在評估 REZZAYO® （雷扎芬淨醋酸鹽）用於預防接受異基因造血幹細胞移植（HSCT）的成年患者患侵襲性真菌病（IFD）的效果。 ReSPECT III期臨床試驗是目前規模最大的抗真菌藥物多中心、隨機、雙盲研究之一，旨在評估每週一次的雷扎芬淨與標準抗菌方案（SAR）相比，在接受異基因造血幹細胞移植（HSCT）的成年受試者中，預防由念珠菌、曲霉菌及肺孢子菌引起的侵襲性真菌病（IFD）的效果。接受異基因造血幹細胞移植的患者需長期接受免疫抑制治療，且通常需要進行長時間的抗真菌預防性治療1，因此，差異化給藥方案、更加完善的副作用控制和更低的藥物交互作用風險意義重大，且預期療效相當。 ReSPECT研究達到了美國食品藥物管理局（FDA）和歐洲藥品管理局（EMA）設定的主要終點，即第90天的無真菌存活率，結果顯示雷扎芬淨與SAR相比具有非劣效性（分別達60.7%和59.0%）。這表明，雷扎芬淨的差異化藥物動力學/藥效學（PK/PD...